MissionIR Articles
-
MissionIRNewsBreaks – Society of Economic Geologists Provides Overview of Saxony’s Mining History, an Area of Focus for Excellon Resources Inc. (NYSE American: EXN) (TSX: EXN) (FSE: E4X2)
The Society of Economic Geologists (“SEG”) Student Chapter from the Freiberg’s University of Mining & Technology, one of the world’s oldest and most traditional mining-focused universities, recently carried out an overview of Germany’s Freiberg and…
-
FingerMotion Inc. (FNGR) Reports Revenue Growth from Mobile Services, Prospects for Further Big Data Services Growth in China
U.S.-based FingerMotion has been pursuing opportunities to provide text and multimedia message services in China, whose population is expected to exceed 1.4 billion people this year FingerMotion is expanding into a third channel of operations…
-
PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) E-commerce Subsidiary Enters Canada D2C Indoor Plant Market Amid Expanding Global Wellness Verticals
PlantX Life Inc. is a growing global presence as a one-stop shopping and educational hub building a sense of community for the world’s plant-based lifestyle pursuits The company announced Oct. 19 that its wholly owned…
-
Tingo International Holdings Teams Up With MELD to Invite $2 Trillion-Dollar Crypto Economy to Invest in African Farmers
Tingo announces partnership with MELD, a DeFi non-custodial banking protocol for secure lending and borrowing of crypto and fiat currencies Two companies share common commitment to bring financial freedom and inclusion to people Tingo aims…
-
Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Completes Refinancing Amid Multi-state Drive to Roll Out Cannabis Brands
Multi-State Operator Red White & Bloom Brands is a cannabis retail opportunity builder expanding via acquisitions to create a synergistic portfolio throughout North America The company recently completed strategic refinancing that reorganizes its debt under…
-
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces New Executives, Internal Promotions
Cybin names Dr. Amir Inamdar as chief medical officer for European operations The company appoints Dr. Geoff Varty as head of research and development Both professionals bring decades of expertise to their new roles as…
-
Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Welcomes Consultancy Prowess as Cannabis Brands Build in Hot Florida Market
Red White & Bloom Brands Inc. is a multi-state operator building steam within the cannabis market, particularly with recent growth developments in Florida and Michigan The company has obtained prequalification status for recreational use marijuana…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Begins Phase 2 Clinical Trial Evaluating CBN in the EB Treatment
InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has started its Phase 2 clinical trial of INM-755 (cannabinol) cream in the treatment of epidermolysis bullosa (“EB”). According to…
-
Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Leading Out in Mental Health Treatment Innovation
WHO survey reports that mental health services in 93% of countries around the world have been disrupted or halted as a result of COVID-19 People with pre-existing mental, neurological or substance-use disorders are more vulnerable…
-
MissionIRNewsBreaks – FingerMotion Inc. (FNGR) Committed to Increasing Market Reach, Product Line, Quality of Offerings
FingerMotion (OTCQX: FNGR) has always endeavored to deliver the next generation of data-driven technology solutions that cut across its current product line and service offerings. Even so, the company, which currently provides solutions to the…
-
InMed Pharmaceuticals Inc. (NASDAQ: INM) Signs Definitive Agreement to Acquire 100% of BayMedica Inc., Positioning it to Stand Distinct in Rare Cannabinoids Manufacturing, Become a Revenue-Generating Company, Expand Drug Development Capabilities
InMed Pharmaceuticals recently announced it has entered a definitive agreement to acquire 100% of BayMedica Inc. BayMedica is a private company that specializes in the manufacture and commercialization of rare cannabinoids Upon closing, the transaction…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at H.C. Wainwright 23rd Annual Global Investment Conference
InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, today announced that its president and CEO Eric. A. Adams will present at the H.C. Wainwright 23rd Annual Global Investment…
-
Flora Growth Corp. (NASDAQ: FLGC) Inks €2M Investment in Hoshi As Part of its European Expansion Plan
Flora closed a €2 million investment in Hoshi International Inc., fulfilling the earlier-announced LOI back in June 2021 This move is set to capitalize on Hoshi’s strong European presence, its technical know-how along with its…
-
PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Bolsters Expansion Plans, Growth Strategy with Launch of Redesigned Shopify-Powered Canadian Website
PlantX’s operations are firmly anchored on three operational focal points, namely products, distribution and community The company is also guided by a growth strategy, under which the e-commerce platform is the main driver of growth…
-
FingerMotion Inc. (FNGR), Its Mission, Market Positioning, and Outlook for the Future
FNGR currently services over a billion users, specifically in the Chinese market It is a company committed to delivering the next generation of data-driven tech solutions across its current product line and service offerings FNGR…
-
AmpliTech Group Inc. (NASDAQ: AMPG) Poised for Anticipated Growth in RF Communications Tech Component Market
Radio frequency (“RF”) technology designer and developer AmpliTech Group is leveraging this year’s Nasdaq uplisting and Russell Microcap Index placement to increase its market visibility AmpliTech builds and markets communications technology products for the satellite…
-
MissionIRNewsBreaks – Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) Supports Continued FDA Enforcement Against Unauthorized ENDS Products, Meets with Regulators
Kaival Brands (NASDAQ: KAVL), the exclusive global distributor of products by Bidi(R) Vapor LLC, is in full support of rules and regulations governing the electronic nicotine delivery systems (“ENDS”) industry; the company also applauds efforts…
-
Brain Scientific Inc. (BRSF) Addresses Critical Neurologist Shortfall with Cost-Effective, Portable Brain Diagnostic Devices
American Academy of Neurology warns of critical neurologist shortfall amid increased incidence of brain disorders Brain Scientific addresses issue with portable, cost-effective brain diagnostic solutions that record EEGs in nearly any setting Product development includes…
-
InMed Pharmaceuticals Inc. (NASDAQ: INM) and Its Quest to Build an Industry-Leading, Rare Cannabinoid Enterprise
InMed announced a non-binding letter of intent to acquire BayMedica Inc. The move is designed to grow InMed’s market presence and strengthen its operations The two companies have had a reciprocal research collaboration that dates…
-
PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Adds Vegan Wines to Growing E-Grocery Portfolio
While all wines are plant-based, not all of them are vegan because traditional winemaking employs animal-based fining agents Vegan wines are clarified and stabilized using either bentonite or natural settlement, but vegans struggle to find…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Marks Pivotal Moment on Path to 2026 Rare Earth Oxide Production
- PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) Marks Bold Entry Into the Growing Battery Storage Market with 4.99 MW BESS in Ontario
- Soligenix Inc. (NASDAQ: SNGX) Working to Advance Heat-Stable Ricin Vaccine with Promising Efficacy
- New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Eyes Bolivia’s Untapped Silver Potential Amid Global Supply Gaps
- MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q2 2025 Results, Advances TPI 287 Toward Phase 2 GBM Trial